Business Update24 Dec 2025, 05:34 pm
Welcure Drugs & Pharmaceuticals Ltd Announces Closure of Trading Window
AI Summary
Welcure Drugs & Pharmaceuticals Ltd has announced the closure of its trading window for all Designated Persons, Designated Employees, Specified Persons, and their immediate relatives. The closure will commence from January 01, 2026, and will last until 48 hours after the declaration of unaudited Standalone Financial Results for the quarter ended December 31, 2025. This decision is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Internal Code of Conduct.
Key Highlights
- Welcure Drugs & Pharmaceuticals Ltd has announced the closure of its trading window.
- The closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
- The trading window will close from January 01, 2026.
- The closure will last until 48 hours after the declaration of unaudited Standalone Financial Results for the quarter ended December 31, 2025.
- The decision affects Designated Persons, Designated Employees, Specified Persons, and their immediate relatives.
Price Impact
More from WELCURE